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THEUNISSEN AND JAENISCH (720), LEE ET AL. (710), LAUGESEN AND HELIN (735),
FLYNN AND CHANG (752), GORKIN ET AL. (762), VOICES (706)
This issue features a series of articles reviewing key areas in stem cell
epigenetics. Theunissen and Jaenisch dissect epigenetic changes
and molecular mechanisms of induced pluripotency, and Lee, Hore,
and Reik discuss epigenetic memory and methylome reprogramming
in development and pluripotent stem cells. Laugesen and Helin
examine chromatin repressive complexes in development and dis-
ease, Flynn and Chang explore the presence and function of lncRNAs
in pluripotent and tissue stemcells, andGorkin, Leung, andRen review
how the 3D genome impacts pluripotency. Finally, we share insights
and predictions from 12 researchers on their view of the field.
SCNT Is Alive and Well!
CHUNG ET AL. (777)
Recentlydeveloped technology that enableshumanSCNT reprogramming
from embryonic cells is also effective with donor cells from adults,
enhancing the therapeutic potential of this approach. Preview by Cibelli.Stem-Cell-Based Models of ALS Find Common Ground
KISKINIS ET AL (781), CHEN ET AL. (796)
Kiskinis et al. define transcriptional and functional changes arising from SOD1 mutations in motor neurons differentiated
from human ALS patient-derived iPSCs, which could be reversed by genome engineering of the SOD1 locus. Using
similar approaches in ALS iPSC-derived motor neurons, Chen et al. identify mutant SOD1 binding to the 30 UTR of neuro-
filament NF-L mRNA as an underlying mechanism for neurofilament aggregation and axonal degeneration. Preview by
Matus et al.
HSCs on a Diet
CHENG ET AL. (810)
Prolonged fasting in mice promotes hematopoietic stem cell self-renewal and regeneration, protects against immuno-
suppression and mortality caused by chemotherapy, and reverses age-dependent myeloid-bias through reducing levels of
IGF-1 and PKA activity. In Translation by Hine and Mitchell. (Top Image.)
Reprogramming a Malignant Niche
MEDYOUF ET AL. (824)
Myelodysplastic syndrome (MDS) stem/progentior cells induce mesenchymal niche cells to adopt an altered expression
pattern, which in turn supports MDS stem cell propagation in vivo. Preview by Raaijmakers.Enhancer Dynamics in Alternate
Pluripotent States
BUECKER ET AL. (838), FACTOR ET AL. (854)
During transition from naive to primed pluripotency, Buecker et al. show
that Oct4 binding as well as enhancer patterns are reorganized, with
collaborating transcription factors such as Otx2 and Zic2/3 mediating
changes in Oct4 binding. Factor et al. report that the transition from
naive to primed pluripotency is regulat ed by activation of ‘‘seed’’
enhancers, which act to maintain pluripotency gene expression and
prepare for transition to a somatic regulatory program. Preview by Van
Bortle and Corces.Klf2 in the Ground State
YEO ET AL. (864)
Mek/Erk inhibition prevents phosphorylation and targeted degrada-
tion of Klf2 to sustain 2i-induced ground state pluripotency. (Bottom
Image.)Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc. xv
